Article Text

Download PDFPDF
The prevalence of essential tremor in rural northern Tanzania
  1. C L Dotchin,
  2. R W Walker
  1. Department of Medicine, North Tyneside District General Hospital, North Shields, Tyne and Wear, UK
  1. Dr C L Dotchin, Department of Medicine, North Tyneside District General Hospital, Rake Lane, North Shields, Tyne and Wear NE29 8NH, UK; catherine.dotchin{at}


Introduction: Estimates of the prevalence of essential tremor (ET) vary widely but there are few existing data on the prevalence of ET in sub-Saharan Africa.

Patients and methods: A door-to-door community based prevalence study of ET was carried out in the Hai district of northern Tanzania (n = 161 071). The screening questionnaire was followed by examination of positive responders and backed up with other case finding methods.

Results: 222 patients responded positively to the screening questions and 43 were referred by village elders. 65 (38 men, 27 women) were diagnosed with ET. Mean age was 72 years and mean duration of symptoms was 11.3 years. The crude prevalence rate was 41/100 000 and age standardised prevalence compared with the UK population (2001) was 82/100 000.

Discussion: This is the first community based prevalence study of ET in sub-Saharan Africa. Previous data from community based neurological surveys showed lower prevalence rates of 5/100 000 in Ethiopia and 10/100 000 in Nigeria. Non-selective β blockers are available locally and are affordable, yet none of these patients had previously been on any treatment.

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.


  • Funding: This study was funded through a grant from the UK Parkinson's disease Society. CD’s salary was provided by Northumbria Healthcare NHS Trust.

  • Competing interests: None.

  • Ethics approval: Ethics approval was obtained from the National Institute of Medical Research in Tanzania and the Newcastle and Northumberland Joint Ethics Committee.